{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Trends in Alzheimer Imaging & Management","title":"Disease-Modifying Therapy, Quantitative Imaging, and AI for Managing Patients with Alzheimer Disease","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/0c6ab2af\"></iframe>","width":"100%","height":180,"duration":1078,"description":"In this discussion, Dr Tanenbaum and Suzie Bash, MD, a Medical Director at RadNet in Los Angeles, cover the intersection of disease-modifying therapies (DMTs), quantitative imaging, and artificial intelligence (AI) in managing Alzheimer disease.","thumbnail_url":"https://img.transistorcdn.com/fHU-kMj-UcnMMXJvObI5RktXs-3A-GNOHex5trnEqVE/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83MDQ2/ZDkxODE0OTE4MmY5/ZDYwNTIxNTg5YWIz/MTViZC5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}